Mira PharmaceuticalsMIRA
13F holders, Q2 2024 (June 30)11holders
4new positions
4sold out
1famous investor
$0.64avg. 13F price*
At the end of Q2 2024, 11 institutions reported holding Mira Pharmaceuticals Inc. (MIRA) in their 13F filings, unchanged from Q1 2024. 4 opened new positions and 4 sold out. The largest holders were Cross Staff Investments Inc ($244K), Avantax Planning Partners, Inc. ($76K) and Suncoast Equity Management ($25K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Mira Pharmaceuticals Inc.
- CUSIP
- 60458C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $116K |
| Exits | 4 | $147K |
All 13F filers, Q1 2024 → Q2 2024: 205,792 shares bought and 134,823 shares sold, net +70,969 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Cross Staff Investments Inc | 0.20% | No change | 383,401 | $244K |
| Avantax Planning Partners, Inc. | 0.00% | New | 118,751 | $76K |
| Suncoast Equity Management | 0.00% | No change | 40,000 | $25K |
| UBS Group AG | 0.00% | Add +519.3% | 29,546 | $19K |
| Praetorian Wealth Management, Inc. | 0.00% | No change | 27,500 | $18K |
| Citadel Advisors | 0.00% | New | 24,396 | $16K |
| Northern Trust Corp. | 0.00% | No change | 20,454 | $13K |
| Bank of New York Mellon Corp | 0.00% | New | 20,001 | $13K |
| First American Bank | 0.00% | No change | 20,000 | $13K |
| Two Sigma Securities, LLC | 0.00% | New | 17,869 | $11K |
| Cary Street Partners Investment Advisory LLC | 0.00% | No change | 10,000 | $6K |
"% of holder's portfolio" is MIRA's weight in each manager's 13F, not the share of Mira Pharmaceuticals Inc. the manager owns.